Loading…
Loading…
New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions d'enquête et de renseignement numériques alimentées par l'IA pour les secteurs
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite offers ~90% recurring revenue and 117% net retention, anchored by mobile forensics leadership and new growth levers. Cellebrite is rated 'Buy' at ~$12, with a Fair Value estimate of $17.3, reflecting ~44% potential upside and a strong GARP profile. I see a narrow moat based on their leadership in mobile forensics, robust rule of X score, and cross-selling opportunities.
/PRNewswire/ -- Cellebrite (Nasdaq: CLBT), leader mondial des solutions d'investigation et de renseignement numériques basées sur l'IA pour les secteurs